NASDAQ · RKDAEnergyOil & Gas Extraction

Arcadia Biosciences news

$0.2807−8.86%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About Arcadia Biosciences

Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire Inc.Jun 11, 8:00 PM ETNeutral

The company is raising capital through a private placement, which is a standard financing activity. While capital raises can indicate funding needs, the announcement itself is factual and routine. The company shows operational progress (Zola volumes up 18% YoY mentioned in related news), but the primary announcement focuses on dilutive equity financing at a modest valuation ($1.03/share), which is neither particularly positive nor negative in isolation.

Arcadia acquires ENGIE Impact to create best-in-class energy management platform
GlobeNewswire Inc.May 1, 9:00 AM ET▲ Positive

Arcadia is acquiring a major competitor with significant scale (1,000+ clients, 20% of Fortune 500), expanding its market reach to 1,500+ customers and 4.5M meters. The acquisition strengthens its platform capabilities and positions it as a comprehensive energy management solution.

Also mentions RKDA

Articles that tag RKDA but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology